SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs quarterly earnings beat and stronger-than-expected outlook, driven by rapidly growing AI data-center demand, sparked a sharp after-hours rally. Many traders welcomed the results as evidence the AI buildout is translating into revenue, while others warned the move could fade and questioned valuation, cash flow, margins, and reliance on data-center spending.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micros strong quarterly results and higher outlook, supported by demand for AI servers, are driving attention. Many traders are bullish on the growth and new CFO, but frustration over the muted share-price reaction is tempered by concerns about margins, cash flow, and lingering doubts about management and financial credibility.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

A letter from 28 HOPE-3 investigators urging FDA approval of deramiocel has renewed attention to Capricors pending Duchenne muscular dystrophy decision, with supporters arguing the trial data warrant approval. Traders are debating that case against concerns about the FDAs prior review and advisory committee vote, while some attribute the share move to short covering; approval remains uncertain.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include core, cognitive adjacencies, and cognitive networks. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Aristas quarterly results topped expectations and its next-quarter outlook came in well above forecasts, with traders citing strong AI-networking demand as the main catalyst. The reaction is broadly bullish, though some are watching for profit-taking and whether the post-earnings jump holds amid valuation concerns.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Midterm election uncertainty is driving discussion, with traders weighing whether a potential Democratic takeover of Congress could weaken Trumps political position and pressure DJT against hopes for a Republican win or a relief rally. The community is sharply divided, and some attribute the stocks rise to election optimism or short covering while others expect a selloff.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas collaboration with Nvidia on an 800V-to-12V power board for next-generation AI data centers is driving attention. Bulls see it as a foothold in AI power infrastructure, while skeptics note that a design collaboration does not guarantee customer orders or meaningful revenue, and question the muted share-price response.

Astera Labs, Inc. provides rack-scale AI infrastructure through purpose-built connectivity solutions. The company offers a range of semiconductor-based connectivity solutions designed to address bandwidth, latency, and reliability challenges in AI and cloud data centers. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs quarterly results and raised outlook are drawing attention, with traders highlighting rapid growth and demand for its AI data-center connectivity products, including Scorpio. The reaction is divided: many see strong fundamentals, while others point to the stocks high valuation and AI-capex uncertainty to explain the sell-the-news decline.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ousters latest quarterly results and stronger revenue outlook are driving discussion, with traders highlighting rapid growth and narrowing losses. Optimism over execution is tempered by concerns about gross margins and volatile price action.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

Ultragenyxs FDA approval of FAYUVI, its gene therapy for Sanfilippo syndrome, is driving renewed attention alongside its recent GENGLYCOS approval. Traders are debating whether the new launches and lower costs can support the companys profitability target, while skeptics point to the stocks weak follow-through despite positive developments.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevras Q3 results are drawing attention, with traders highlighting an earnings beat, roughly in-line revenue and a larger cash position while debating why the share-price response has been muted. Discussion also centers on a planned MIPLYFFA pediatric label expansion and whether FDA feedback could support a more efficient celiprolol pathway; both remain future regulatory possibilities.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Dell Technologies ($DELL) has completed wave ((3)) and is now undergoing a wave ((4)) corrective pullback. Downside targets for this corrective phase are projected toward the $311.24 support area before the broader impulse structure resumes and leads a rally back toward all-time highs 
 
Read more here 👉 https://elliottwave-forecast.com/stock-market/dell-technologies-dell-elliott-wave-forecast/ 
 
#trading #Elliottwave

Dell Technologies (NYSE: DELL) maintains a bullish long-term Elliott Wave outlook following its strong rally toward $600. The weekly chart suggests that the stock is progressing within a larger impulsive...

Elliott Wave Forecast: Elliott Wave Trading Signals & Forecast

Dell Technologies : Wave ((4)) Correction Could Offer Potential Buying Opportunities

StockTwits Web

Dell Technologies Inc

) has completed wave ((3)) and is now undergoing a wave ((4)) corrective pullback. Downside targets for this corrective phase are projected toward the $311.24 support area before the broader impulse structure resumes and leads a rally back toward all-time highs 
 
Read more here 👉 

Elliottwave Forecast

$DELL 311.24 is the line to watch here. A clean hold there keeps the wave 4 pullback contained and the move back toward highs live. Lose it and the correction gets room to run lower.

 311.24 is the line to watch here. A clean hold there keeps the wave 4 pullback contained and the move back toward highs live. Lose it and the correction gets room to run lower.